Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : email@example.com
SRF617 is a monoclonal antibody that binds to CD39 and inhibits the conversion of ATP to AMP, potentially resulting in enhanced adaptive and innate immune response against tumor cells (NCI Thesaurus).
|DrugClasses||CD39 Antibody 4|
|CAS Registry Number||NA|
|Therapy Name||Drugs||Efficacy Evidence||Clinical Trials|
|AB928 + SRF617 + Zimberelimab||AB928 SRF617 Zimberelimab||0||1|